TidalHealth has become a regional referral site for the administration of a new type of Covid-19 treatment that drew attention when it was used to treat President Trump. Bamlanivimab, a monoclonal antibody produced by Eli Lilly & Co., was granted emergency use authorization by the Food & Drug Administration on Nov. 9. Only six hospitals […]
Source: The Salisbury Independent
Be First to Comment